myocardial infarction: Gross necrosis of the myocardium, as a result of interruption of the blood supply to the area, as in coronary thrombosis.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
309 |
4. Check minimum number of eventsNone |
309 |
5. Include endpointsNone |
309 |
6. Filter based on genotype QC (FinnGen only) |
309 |
Control definitions (FinnGen only)
- Control exclude
- I9_ISCHHEART
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- I20-I25
- Name in latin
- Aliquae complicationes post infarctum myocardii acutum
Similar endpoints
↥List of similar endpoints to
Complications following myocardial infarction
based on the number of shared cases.
Similar with more cases:
- Ischaemic heart disease, wide definition
- Ischemic heart diseases
- Cardiovascular diseases (excluding rheumatic etc)
- Cardiovascular diseases
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 4502 | 1945 | 2459 |
| Only index persons | 2275 | 934 | 1341 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.06 | 0.06 | 0.07 |
| Only index persons | 0.04 | 0.03 | 0.05 |
| Median age at first event (years) | |||
| Whole population | 74.10 | 77.64 | 71.22 |
| Only index persons | 72.79 | 77.27 | 69.66 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 309 | 83 | 226 |
| Unadjusted period prevalence (%) | 0.08 | 0.03 | 0.10 |
| Median age at first event (years) | 71.35 | 72.11 | 71.07 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 276
- Matched controls
- 2758
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
I23.0
ICD-10 Finland
Haemopericardium as current complication following acute myocardial infarction
+∞
172.6
147
*
I25.1
ICD-10 Finland
Atherosclerotic heart disease
135.2
105.5
108
13
I25.2
ICD-10 Finland
Old myocardial infarction
310.8
72.0
70
*
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
28.8
69.3
96
50
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
15.3
57.0
101
100
I21.9
ICD-10 Finland
Acute myocardial infarction, unspecified
+∞
48.4
45
*
I21.0
ICD-10 Finland
Acute transmural myocardial infarction of anterior wall
+∞
42.8
40
*
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
59.2
42.4
49
10
FN1AT
NOMESCO Finland
Endovascular dilatation of coronary arteries (PTCA)
+∞
41.7
39
*
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
394.6
35.8
35
*
AN1
HP
Coronary angiography
15.0
34.5
59
49
FN1YT
NOMESCO Finland
Percutaneous insertion of coronary artery stent
+∞
33.0
31
*
I21.2
ICD-10 Finland
Acute transmural myocardial infarction of other sites
+∞
30.8
29
*
I23.1
ICD-10 Finland
Atrial septal defect as current complication following acute myocardial infarction
+∞
29.7
28
*
I23.2
ICD-10 Finland
Ventricular septal defect as current complication following acute myocardial infarction
+∞
29.7
28
*
I21.1
ICD-10 Finland
Acute transmural myocardial infarction of inferior wall
+∞
29.7
28
*
I23.8
ICD-10 Finland
Other current complications following acute myocardial infarction
+∞
29.7
28
*
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
+∞
29.7
28
*
I23.6
ICD-10 Finland
Thrombosis of atrium, auricular appendage, and ventricle as current complications following acute myocardial infarction
+∞
28.6
27
*
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
36.2
27.6
35
11
81
HP
Angiography of the heart and coronary arteries
23.5
26.0
37
18
FNA01
NOMESCO Finland
Anastomosis to coronary artery from internal mammary artery, one distal anastamosis
+∞
24.3
23
*
I21.01
ICD-10 Finland
Acute transmural myocardial infarction of anterior wall
+∞
23.2
22
*
C01DA14
ATC
isosorbide mononitrate; oral
6.0
23.1
69
144
I20.99
ICD-10 Finland
Angina pectoris, unspecified
249.8
23.0
23
*
I20.09
ICD-10 Finland
Unstable angina
+∞
22.2
21
*
FN2BA
NOMESCO Finland
Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)
+∞
21.1
20
*
I21.99
ICD-10 Finland
Myocardial infarction (acute) UNS unspecified coronary artery status
+∞
20.0
19
*
I21.41
ICD-10 Finland
Acute subendocardial infarction stenosed coronary artery
+∞
20.0
19
*
I21.19
ICD-10 Finland
Acute transmural myocardial infarction of inferior wall
+∞
20.0
19
*
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
79.1
20.0
22
*
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
+∞
19.0
18
*
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
3.9
18.2
87
290
I21.00
ICD-10 Finland
Acute transmural myocardial infarction of anterior wall
+∞
17.9
17
*
I20.90
ICD-10 Finland
Angina pectoris, unspecified
+∞
17.9
17
*
I20.00
ICD-10 Finland
Unstable angina
+∞
16.8
16
*
I21.09
ICD-10 Finland
Acute transmural myocardial infarction of anterior wall
+∞
16.8
16
*
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
3.9
16.7
77
247
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
20.7
15.8
23
12
I20.01
ICD-10 Finland
Unstable angina
+∞
15.8
15
*
Z95.5
ICD-10 Finland
Presence of coronary angioplasty implant and graft
60.1
15.0
17
*
11
HP
Coronary artery bypass surgery
+∞
14.7
14
*
AN3
HP
Balloon angioplasty and metallic stent
+∞
14.7
14
*
B01AC04
ATC
clopidogrel; oral
4.5
14.7
55
144
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
20.5
14.5
21
11
82
HP
Single vessel balloon catheter extension
+∞
13.6
13
*
I21.90
ICD-10 Finland
Myocardial infarction (acute) UNS no detected stenosis of the coronary artery
+∞
13.6
13
*
AA1
HP
Conventional CABG
+∞
12.6
12
*
I21.10
ICD-10 Finland
Acute transmural myocardial infarction of inferior wall
+∞
12.6
12
*
AN2
HP
Balloon angioplasty, including several vessels
+∞
12.6
12
*
B01AC06
ATC
acetylsalicylic acid; oral (platelet aggregation inhibitors excl. heparin)
16.9
12.3
19
12
FXG00
NOMESCO Finland
Insertion and use of IABP
+∞
11.5
11
*
FNC20
NOMESCO Finland
Aorto-coronary venous bypass with two distal anastomoses
+∞
11.5
11
*
4100X
ICD-9 Finland
Acute myocardial infarction, Of anterolateral wall[INFARCTUS MYOCARDII ACUTUS DEFINITUS,MÄÄRITTELEMÄT]
+∞
11.5
11
*
I23.5
ICD-10 Finland
Rupture of papillary muscle as current complication following acute myocardial infarction
+∞
11.5
11
*
B01AA03
ATC
warfarin; systemic
2.6
11.0
98
478
I25.5
ICD-10 Finland
Ischaemic cardiomyopathy
114.1
10.5
11
*
I21.11
ICD-10 Finland
Acute transmural myocardial infarction of inferior wall
+∞
10.5
10
*
I20.89
ICD-10 Finland
Other angina pectoris unspecified coronary artery status
57.0
9.7
11
*
I21.40
ICD-10 Finland
Acute subendocardial infarction no detected stenosis of the coronary artery
103.4
9.5
10
*
FHA20
NOMESCO Finland
Closure of VSR in posteroseptal myocardial infarction
+∞
9.4
9
*
A98
ICPC
Health maint/preventive medicine
0.5
9.2
128
1811
FNC10
NOMESCO Finland
Aorto-coronary venous bypass with single distal anastomosis
+∞
8.4
8
*
AN4
HP
Balloon angioplasty and drug eluding stent
+∞
8.4
8
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.9
8.3
54
215
201
Kela drug reimbursment
Chronic cardiac insufficiency
4.1
7.9
30
80
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.8
7.8
52
211
I47.2
ICD-10 Finland
Ventricular tachycardia
12.3
7.7
13
11
R07.4
ICD-10 Finland
Chest pain, unspecified
2.5
7.4
61
280
FNC30
NOMESCO Finland
Aorto-coronary venous bypass with three distal anastomoses
+∞
7.3
7
*
I23
ICD-10 Finland
Certain current complications following acute myocardial infarction
+∞
7.3
7
*
I23.3
ICD-10 Finland
Rupture of cardiac wall without haemopericardium as current complication following acute myocardial infarction
+∞
7.3
7
*
C08CA07
ATC
nisoldipine; oral
30.9
7.2
9
*
AP1
HP
Catheterization of the left side of the heart
20.7
7.2
10
5
I25
ICD-10 Finland
Chronic ischaemic heart disease
20.7
7.2
10
5
C09AA05
ATC
ramipril; oral
2.2
7.0
82
445
N02BE01
ATC
paracetamol; systemic, rectal
0.5
6.8
136
1809
61
HP
Catheterization and pressure measurement of the left side of the heart
23.2
6.7
9
*
ZXD00
NOMESCO Finland
Emergency procedure
7.7
6.5
14
19
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
4.2
6.4
23
59
FN1BT
NOMESCO Finland
Extensive endovascular dilatation of coronary (PTCA) arteries
+∞
6.3
6
*
B01AC24
ATC
ticagrelor; oral
+∞
6.3
6
*
AM2
HP
Surgery of infarction complication eg VSR, aneurysm, rupture of papillary muscle
+∞
6.3
6
*
C07AB02
ATC
metoprolol; systemic
2.2
6.1
69
365
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
149
2026
0.49
8.69
12.0
10.5
u/l
29.0
24.6
0.59
135
1915
(3010813) Leukocytes [#/volume] in Blood
159
2106
0.50
8.37
33.6
23.6
e9/l
7.6
7.0
2.60
146
2009
(3026361) Erythrocytes [#/volume] in Blood
159
2106
0.50
8.37
33.5
23.5
e12/l
4.3
4.4
0.91
146
2009
(3035941) MCH [Entitic mass]
159
2106
0.50
8.37
33.5
23.4
pg
30.4
30.5
0.36
147
2035
(3000963) Hemoglobin [Mass/volume] in Blood
159
2106
0.50
8.37
33.9
23.7
g/l
130.4
133.6
1.31
149
2033
(3024731) MCV [Entitic volume]
159
2106
0.50
8.37
33.4
23.5
fl
91.9
91.9
0.05
147
2036
(3007461) Platelets [#/volume] in Blood
159
2105
0.50
8.33
33.5
23.6
e9/l
226.3
235.8
1.14
147
2017
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
127
1797
0.50
7.94
25.1
15.6
ml/min/173m2
69.3
71.6
0.54
106
1486
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
144
1951
0.51
7.77
25.4
16.4
mg/l
29.2
29.4
0.03
117
1589
(3019550) Sodium [Moles/volume] in Serum or Plasma
157
2054
0.52
7.28
29.6
18.9
mmol/l
139.7
139.6
0.15
144
1972
(3023103) Potassium [Moles/volume] in Serum or Plasma
158
2062
0.52
7.25
29.8
18.9
mmol/l
4.1
4.0
1.23
143
1982
(40761511) CBC panel - Blood by Automated count
150
1986
0.52
7.16
21.6
15.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
29
696
0.36
6.94
2.6
3.2
ug/l
1.2
0.8
0.42
19
486
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
22
64
3.62
6.70
3.3
2.0
u/ml
0.4
0.4
0.25
12
33
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
50
924
0.45
6.29
3.5
4.7
%
24.3
21.8
0.72
25
478
(3009261) Glucose [Presence] in Urine by Test strip
57
982
0.49
5.77
3.8
4.2
estimate
0.0
0.0
0.00
13
175
(3021601) Nitrite [Presence] in Urine by Test strip
57
967
0.50
5.43
5.6
5.8
estimate
0.0
0.0
—
10
178
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
114
1570
0.57
5.39
9.6
7.5
u/l
88.6
83.2
0.56
101
1430
(3035350) Ketones [Presence] in Urine by Test strip
57
964
0.50
5.37
3.7
4.1
estimate
0.0
0.0
0.00
13
180
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
142
1841
0.58
5.31
5.2
4.8
mmol/l
2.3
2.7
4.34
125
1592
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
142
1839
0.58
5.27
4.7
4.8
mmol/l
6.5
6.1
2.40
116
1591
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
37
166
2.40
5.26
3.7
2.1
ug/l
7.3
4.9
0.60
28
132
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
136
1772
0.58
5.05
4.8
4.3
mmol/l
4.2
4.5
3.19
122
1555
(3013707) Erythrocyte sedimentation rate by Westergren method
104
1449
0.57
4.95
4.6
3.9
mm/h
15.9
14.6
0.34
90
1307
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
134
1748
0.59
4.95
4.8
4.4
mmol/l
1.3
1.4
3.01
119
1513
(3037467) Urinalysis macro (dipstick) panel - Urine
100
1404
0.57
4.87
4.4
4.7
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
130
1705
0.59
4.86
4.8
4.2
mu/l
2.2
2.0
0.28
108
1465
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
75
1138
0.55
4.83
3.9
5.6
ug/l
2.7
3.3
0.42
60
980
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
139
1790
0.59
4.81
6.8
6.3
mmol/mol
44.1
40.8
2.43
124
1589
(3044889) 12 lead EKG panel
97
1367
0.58
4.74
5.1
3.9
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
47
818
0.50
4.70
5.9
4.0
e6/l
258.3
101.9
0.61
34
605
(3003338) MCHC [Mass/volume]
112
1500
0.60
4.32
33.1
21.1
g/l
330.2
331.8
0.85
107
1476
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
45
769
0.51
4.17
3.7
4.6
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
111
1481
0.61
4.15
29.6
19.9
%
14.4
14.0
1.74
104
1435
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
133
1691
0.63
3.96
4.4
3.9
mmol/l
1.4
1.3
1.61
118
1447
(3009542) Hematocrit [Volume Fraction] of Blood
129
1650
0.63
3.93
26.1
17.5
%
38.4
38.2
0.07
71
1006
(3041096) Erythrocytes [Presence] in Urine by Automated
28
545
0.47
3.77
3.6
4.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
24
491
0.45
3.69
1.4
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
50
797
0.56
3.59
2.6
2.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
45
735
0.55
3.51
4.7
3.5
e6/l
70.2
85.1
0.10
35
572
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
56
851
0.58
3.33
4.7
3.5
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
36
610
0.54
3.14
4.9
3.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
54
814
0.59
3.08
2.7
2.1
nmol/l
75.7
76.4
0.07
46
682
(3021960) Folate [Moles/volume] in Serum or Plasma
34
577
0.54
2.97
1.8
1.6
nmol/l
14.0
20.2
3.02
28
467
(3030467) Casts [#/volume] in Urine by Automated count
41
658
0.57
2.94
4.7
3.4
e6/l
0.3
0.6
0.65
29
501
(3026782) Osmolality of Urine
28
502
0.51
2.92
3.5
2.9
mosm/kgh2o
554.8
577.8
0.42
23
418
(3015736) pH of Urine
50
759
0.59
2.91
3.5
3.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
85
1128
0.66
2.69
3.0
3.2
u/l
137.7
56.4
1.00
70
1026
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
65
912
0.64
2.68
7.3
4.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
104
1323
0.68
2.64
4.2
3.5
pmol/l
15.3
15.2
0.15
83
1134
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
80
1067
0.66
2.57
7.0
6.4
umol/l
11.9
12.6
0.26
75
991
(3013650) Neutrophils [#/volume] in Blood by Automated count
82
1088
0.66
2.56
11.0
8.9
e9/l
4.7
4.5
0.47
69
931
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
62
870
0.64
2.53
3.0
2.4
—
—
—
0
0
(3002256) Pathology report gross observation
13
288
0.43
2.44
1.6
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
34
547
0.57
2.43
3.3
4.3
estimate
0.0
0.0
0.00
11
165
(3019150) Specific gravity of Urine by Refractometry
25
433
0.54
2.32
3.7
4.5
kg/l
1.0
1.0
—
5
64
(3013826) Glucose [Moles/volume] in Serum or Plasma
100
1251
0.70
2.19
7.0
4.1
mmol/l
7.7
6.8
1.36
94
1177
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
72
955
0.68
2.17
2.0
2.1
pmol/l
91.7
91.9
0.02
40
489
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
11
43
2.62
2.12
3.3
1.7
%
83.5
82.3
0.06
11
38
(3018418) pH of Serum or Plasma
46
665
0.64
2.11
5.6
3.4
ph
7.4
7.4
—
10
128
(3000850) Epithelial cells [#/volume] in Urine
33
512
0.60
2.04
3.3
2.7
e6/l
4.9
3.8
0.29
25
436
(3021589) Normoblasts [#/volume] in Blood
61
826
0.67
2.03
13.0
9.8
e9/l
0.0
0.0
0.65
50
663
(3019230) Fractional oxyhemoglobin in Venous blood
8
26
3.13
2.02
4.4
1.6
%
73.7
59.8
—
8
26
(3018010) Neutrophils/100 leukocytes in Blood
67
888
0.69
1.99
8.2
5.5
%
62.5
59.8
1.05
55
809
(3013115) Eosinophils [#/volume] in Blood
75
969
0.70
1.92
7.2
5.3
e9/l
0.2
0.2
0.39
61
829
(3019069) Monocytes/100 leukocytes in Blood
68
884
0.70
1.78
7.6
5.6
%
8.9
9.0
0.12
56
803
(3033658) Prothrombin time (PT) actual/Normal
34
504
0.63
1.73
8.1
3.6
%
76.5
81.7
0.54
34
496
(3006504) Eosinophils/100 leukocytes in Blood
68
880
0.71
1.73
8.2
5.3
%
3.0
2.9
0.09
58
798
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
33
489
0.64
1.68
3.8
3.3
mmol/l
2.5
2.5
0.09
27
421
(3002030) Lymphocytes/100 leukocytes in Blood
71
908
0.72
1.68
7.2
5.7
%
23.2
24.7
0.61
60
816
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
24
382
0.60
1.65
4.4
3.3
e6/l
1.2
1.5
0.16
13
229
(3022096) Basophils/100 leukocytes in Blood
67
863
0.71
1.65
7.3
5.3
%
0.7
0.6
0.60
56
780
(3024561) Albumin [Mass/volume] in Serum or Plasma
77
969
0.73
1.64
5.9
4.3
g/l
33.1
34.3
0.99
67
885
(1761868) Lipid panel - Serum or Plasma
37
530
0.66
1.61
3.1
3.0
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
90
1103
0.74
1.61
10.5
5.6
mmol/l
1.2
1.2
0.64
72
903
(3001604) Monocytes [#/volume] in Blood
74
934
0.73
1.60
6.9
5.2
e9/l
0.6
0.6
0.29
58
777
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
25
388
0.61
1.56
4.1
3.1
e6/l
0.7
1.2
1.02
13
233
(3044640) Blood type and Crossmatch panel - Blood
52
693
0.70
1.55
4.8
2.6
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
75
936
0.74
1.49
6.9
5.2
e9/l
0.0
0.0
0.51
61
788
(3000991) Gas panel - Venous blood
27
173
1.61
1.46
11.6
6.9
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
16
89
1.84
1.40
13.1
9.5
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
78
956
0.75
1.35
6.7
5.4
e9/l
1.6
1.8
1.01
65
823
(3022621) pH of Urine by Test strip
7
150
0.45
1.35
3.3
3.9
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
83
1007
0.76
1.33
9.3
5.0
mmol/l
1.2
1.2
0.99
74
880
(3015377) Calcium [Moles/volume] in Serum or Plasma
61
768
0.74
1.27
3.0
3.2
mmol/l
2.3
2.3
0.01
51
645
(3000330) Specific gravity of Urine by Test strip
6
126
0.47
1.19
4.3
4.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
51
653
0.74
1.18
8.2
5.3
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
0
35
0.00
1.16
0.0
1.2
—
2.3
—
0
27
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
0
35
0.00
1.16
0.0
1.4
—
268.6
—
0
28
(3013512) EKG study
56
704
0.75
1.15
5.0
3.9
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
7
138
0.50
1.12
1.3
1.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
32
438
0.70
1.11
3.4
4.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
8
41
1.98
1.09
5.9
1.6
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
5
23
2.19
0.98
1.6
1.4
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
0
29
0.00
0.98
0.0
2.7
—
53.7
—
0
21
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
17
110
1.58
0.92
1.8
2.5
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
8
43
1.88
0.88
1.4
1.5
g/l
0.3
0.3
—
8
43
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
40
507
0.76
0.87
1.7
1.8
pmol/l
400000391.3
14214890.2
0.46
31
401
(3026493) Urate [Moles/volume] in Serum or Plasma
42
528
0.76
0.86
3.5
2.8
umol/l
13017.3
10790.2
0.06
34
433
(40761536) Microorganisms panel - Urine sediment
11
178
0.60
0.86
5.4
4.0
—
—
—
0
0
(3000492) Spirometry study
8
139
0.56
0.85
1.3
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
15
225
0.65
0.85
1.3
1.3
u/ml
1.2
19.3
—
6
71
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
8
45
1.80
0.85
1.5
1.5
g/l
1.1
1.2
—
8
45
(3023183) Ammonium ion [Moles/volume] in Plasma
8
45
1.80
0.85
1.5
2.4
umol/l
38.9
34.3
—
8
36
(3026008) Bacteria identified in Urine by Culture
60
714
0.80
0.79
3.6
3.7
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.1
—
309.8
—
0
12
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
8
48
1.68
0.79
3.4
2.1
g/l
3.6
3.9
—
8
43
(40760888) Immunoglobulin light chains.free panel - Serum
8
48
1.68
0.79
2.6
3.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
9
55
1.66
0.74
4.6
2.8
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
19
263
0.70
0.73
2.1
4.6
ug/l
9.7
61.7
0.98
14
219
(3012516) Albumin [Mass/volume] in Urine
49
590
0.80
0.72
3.5
3.3
mg/l
68.6
241.5
0.73
35
395
(3003327) Ova and parasites identified in Stool by Light microscopy
7
40
1.77
0.71
1.9
1.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
84
732
1.20
0.71
4.0
2.9
ng/l
2106.9
1929.0
0.16
74
612
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
41
503
0.79
0.71
3.9
2.6
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
53
631
0.81
0.71
2.7
2.0
u/l
243.0
354.7
0.40
48
590
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
7
41
1.72
0.70
1.3
1.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
5
93
0.53
0.68
4.8
4.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
30
234
1.31
0.66
2.6
1.6
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
46
381
1.24
0.64
43.7
27.2
inr
2.2
1.5
—
7
43
(40758558) Short blood count panel - Blood
38
462
0.80
0.62
8.4
6.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
26
201
1.32
0.61
5.2
3.2
mmol/l
1.4
1.8
0.18
15
145
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
8
51
1.58
0.61
1.0
1.2
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
0
20
0.00
0.60
0.0
1.3
—
59078.1
—
0
15
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
3.4
—
49.4
—
0
20
(3026389) Candida sp identified in Specimen by Organism specific culture
0
21
0.00
0.60
0.0
1.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
22
0.00
0.59
0.0
2.0
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
16
116
1.40
0.55
14.1
7.4
mmol/l
23.5
24.8
1.07
16
116
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
46
388
1.22
0.55
6.8
2.9
ng/l
3399.1
355.7
0.90
39
327
(3027945) Reticulocytes/100 erythrocytes in Blood
35
287
1.25
0.54
2.2
2.5
%
1.8
1.7
0.09
28
252
(3009508) Creatinine [Moles/volume] in Urine
51
591
0.84
0.53
3.5
3.2
mmol/l
7.4
7.7
0.12
43
470
(3001122) Ferritin [Mass/volume] in Serum or Plasma
67
758
0.85
0.53
3.3
2.3
ug/l
137.1
180.6
1.03
58
669
(4035726)
13
178
0.72
0.50
1.7
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
14
189
0.73
0.50
4.2
3.8
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
18
233
0.76
0.49
1.3
1.2
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
14
103
1.38
0.46
2.1
2.5
%
1.4
1.2
0.21
14
103
(3049717) Cytology report of Urine Cyto stain
9
131
0.68
0.44
4.4
3.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
5
32
1.57
0.42
1.2
1.5
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
13
172
0.75
0.42
1.9
2.1
nmol/l
13.5
12.5
0.12
13
149
(3003396) Base excess in Arterial blood by calculation
29
241
1.22
0.42
10.6
6.0
mmol/l
0.3
1.3
0.59
19
184
(40768806) Pleura Pathology biopsy report
5
33
1.52
0.41
1.4
1.7
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
33
1.52
0.41
2.8
2.4
e9/l
4.7
4.8
—
5
33
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
15
0.00
0.41
0.0
1.3
—
7.7
—
0
8
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
15
0.00
0.41
0.0
4.5
—
90.0
—
0
15
(3017569) Oxygen content in Arterial blood
0
15
0.00
0.41
0.0
2.2
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
8
59
1.37
0.41
1.0
1.1
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
0
16
0.00
0.41
0.0
2.9
—
713.9
—
0
8
(3024263) Appearance of Synovial fluid
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
17
0.00
0.41
0.0
1.0
—
296.3
—
0
6
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
17
0.00
0.41
0.0
1.0
—
440.6
—
0
7
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
17
0.00
0.41
0.0
1.1
—
44.2
—
0
6
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
17
0.00
0.41
0.0
1.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
34
1.48
0.40
2.8
2.6
%
65.4
62.9
—
5
34
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
7
103
0.67
0.40
1.0
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
20
247
0.80
0.39
2.9
3.8
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
25
206
1.23
0.39
2.3
2.7
e9/l
63.4
64.7
0.06
18
168
(46235355) HIV 1 and 2 tests - Meaningful Use set
13
170
0.75
0.39
1.7
1.5
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
66
728
0.88
0.37
4.9
4.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
21
173
1.23
0.34
1.2
2.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
49
547
0.88
0.33
2.1
1.8
nmol/l
1283.7
1183.8
0.30
36
397
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
6
89
0.67
0.33
3.2
3.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
7
53
1.33
0.31
1.1
1.6
—
—
—
0
0
(4010399)
15
120
1.26
0.30
1.3
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
7
54
1.30
0.30
1.1
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
24
280
0.85
0.29
2.0
1.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
13
161
0.80
0.28
1.5
1.2
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
27
310
0.86
0.27
3.1
1.9
g/l
2.2
2.2
0.04
22
275
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
14
113
1.25
0.27
2.3
1.8
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
8
67
1.20
0.26
1.4
1.3
—
—
—
0
0
(3019225) pH of Specimen
27
235
1.16
0.26
4.6
4.0
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
28
245
1.16
0.25
10.8
5.9
kpa
4.9
5.1
0.92
23
231
(3020682) Albumin/Creatinine [Ratio] in Urine
58
629
0.90
0.25
3.8
4.0
mg/mmol
7.2
11.4
0.64
42
416
(3027801) Oxygen [Partial pressure] in Arterial blood
28
246
1.15
0.24
10.8
5.9
kpa
11.6
11.6
0.02
23
234
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
40
1.25
0.22
1.0
1.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
41
1.22
0.22
1.6
1.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
32
287
1.13
0.22
1.7
1.3
g/l
2.6
2.7
0.12
21
155
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.7
—
922.8
—
0
11
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
2.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
8
103
0.77
0.21
1.0
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(4027681)
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
5
43
1.17
0.21
1.0
2.6
—
16.4
—
0
22
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
13
0.00
0.21
0.0
4.8
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
13
0.00
0.21
0.0
2.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
13
0.00
0.21
0.0
2.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
14
0.00
0.20
0.0
16.3
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
16
137
1.18
0.19
4.3
4.1
mmol/l
-0.1
1.5
—
7
100
(3027315) Oxygen [Partial pressure] in Blood
6
52
1.16
0.19
3.5
4.2
kpa
7.8
7.9
—
6
52
(3013290) Carbon dioxide [Partial pressure] in Blood
6
52
1.16
0.19
3.5
4.2
kpa
4.8
5.2
—
6
52
(3014765) Yersinia sp identified in Stool by Organism specific culture
8
68
1.18
0.16
1.4
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
8
69
1.16
0.16
1.4
1.3
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
10
83
1.21
0.15
1.0
1.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
23
207
1.12
0.15
1.6
2.3
g/l
66.4
65.5
0.23
18
176
(3022313) Gas panel - Capillary blood
13
112
1.17
0.14
4.9
4.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
84
874
0.95
0.14
4.5
3.4
ng/l
264.4
30.5
1.32
61
664
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
8
99
0.80
0.14
1.5
2.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
12
138
0.86
0.13
1.8
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
26
282
0.91
0.12
2.0
1.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
12
136
0.88
0.11
1.6
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
31
330
0.93
0.10
1.3
1.2
u/ml
0.6
0.9
—
9
80
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
15
165
0.90
0.09
2.1
1.6
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
27
287
0.94
0.08
3.0
1.9
%
21.1
23.1
0.39
20
246
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
10
88
1.14
0.08
1.3
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
7
67
1.05
0.08
1.6
1.1
u/ml
119.3
242.0
—
7
61
(21494755) Public health laboratory ask at order entry panel
6
70
0.85
0.07
1.0
1.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
19
176
1.08
0.07
1.6
1.7
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
59
571
1.04
0.07
2.4
2.0
mg/l
3.4
3.1
0.38
43
470
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
7
83
0.84
0.07
2.1
1.7
—
—
—
0
0
(3020891) Body temperature
9
88
1.02
0.07
2.6
4.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
35
366
0.95
0.07
5.9
4.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
12
132
0.91
0.06
1.8
1.5
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
92
940
0.97
0.06
27.1
10.6
inr
1.7
1.4
1.68
26
262
(3025941) Bacteria identified in Stool by Culture
9
101
0.89
0.06
1.2
1.3
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
12
109
1.10
0.06
4.3
3.9
%
44.7
46.8
0.10
12
109
(3019060) Gas panel - Arterial blood
13
141
0.92
0.05
4.8
3.9
—
—
—
0
0
(3009343) pH of Capillary blood
16
149
1.08
0.05
4.6
4.0
—
7.4
—
0
15
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
14
151
0.92
0.05
2.4
2.8
ml/min/173m2
62.7
56.7
—
9
60
(3042936) Bacteria identified in Isolate by Culture
32
308
1.04
0.04
2.7
1.9
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
29
280
1.04
0.03
9.7
7.6
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
11
103
1.07
0.02
2.6
1.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
24
233
1.03
0.01
1.3
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
40
393
1.02
0.01
1.9
1.6
mg/l
2.3
1.6
0.40
32
308
(3022145) Colonoscopy Study observation
18
186
0.97
0.00
1.3
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
15
148
1.01
0.00
1.7
1.8
%
1.5
1.7
0.64
15
123
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
42
418
1.01
0.00
2.0
1.7
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
87.2
—
0
5
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
157.6
—
0
5
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
5
0.00
0.00
0.0
3.4
—
13.7
—
0
5
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(4211845)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
6
0.00
0.00
0.0
4.7
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
7
0.00
0.00
0.0
3.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
55
0.91
0.00
1.6
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
8
81
0.99
0.00
1.6
1.3
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
5
59
0.84
0.00
1.8
1.6
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
8
84
0.95
0.00
1.0
1.2
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
55
0.91
0.00
1.6
1.4
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
23.2
—
0
7
(3010421) pH of Blood
6
60
1.00
0.00
3.5
4.0
ph
7.4
7.4
—
6
52
(3004716) Salmonella sp identified in Stool by Organism specific culture
8
81
0.99
0.00
1.4
1.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
8.1
—
0
7
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.7
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(4015189)
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
8
0.00
0.00
0.0
1.0
—
8.8
—
0
8
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(44813793)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint I9_MI_COMPLICATIONS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_MI_COMPLICATIONS | 2.357 [1.88, 2.95] | < 0.001 |
| Birth year | 0.999 [0.99, 1.01] | 0.801 |
During the follow-up period (1.1.1998 — 31.12.2019), 329 out of 499 females with I9_MI_COMPLICATIONS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_MI_COMPLICATIONS | 2.412 [1.98, 2.93] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.006 |
During the follow-up period (1.1.1998 — 31.12.2019), 427 out of 704 males with I9_MI_COMPLICATIONS died.
Mortality risk
Mortality risk for people of age
years, who have I9_MI_COMPLICATIONS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.256% | 0.471% |
| 5 | 1.612% | 2.737% |
| 10 | 4.016% | 6.797% |
| 15 | 7.708% | 13.221% |
| 20 | 13.262% | 21.439% |
Relationships between endpoints
↥Index endpoint: I9_MI_COMPLICATIONS – Complications following myocardial infarction
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data